Pharma News – May 2020

COVID-19 Vaccine Development Moderna Announces Positive Interim Data of COVID-19 mRNA Vaccine On 18th May 2020, Moderna Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, [...]

Pharma News – April 2020

COVID-19 Vaccine Development Sanofi and GlaxoSmithKline (GSK) Collaborate in Adjuvanted Vaccine for Coronavirus (COVID-19)  On 14th April 2020, Sanofi and GSK announced that they have signed a letter of intent for a collaboration focused on development [...]

21-April-2020|Blog, Pharma News|

Pharma News – March 2020

COVID-19 Vaccine Development National Institutes of Health (NIH) Initiates Clinical Trial of Investigational Vaccine for COVID-19 On 16th March 2020, the NIH announced that the first United States (US) clinical [...]

25-March-2020|Blog, Pharma News|

Regulatory News – March 2020

Guidance Documents on the Management of Clinical Trials during the COVID-19 (Coronavirus) pandemic Released in March European Medicines Agency (EMA), Food and Drug Administration (FDA) and Medicines and Healthcare products [...]

Regulatory News – February 2020

LABORATORIES New documents or drafts for comment  There are no new Organisation for Economic Co-operation and Development (OECD) documents or drafts released for comment since the August update, however, it is anticipated that the OECD [...]

27-February-2020|Blog, Regulatory News|

Pharma News – February 2020

GSK and CEPI Joint Collaboration for Development of Coronavirus Vaccine On 3rd February 2020, the Coalition for Epidemic Preparedness Innovations (CEPI) and GlaxoSmithKline (GSK) have announced a new collaboration aimed [...]

19-February-2020|Blog, Pharma News|